Frontlight ResearchEarly access
Trial site
Epilepsiezentrum Kleinwachau gGmbH
- 4running trials
- 5closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Epilepsy9 trials
- Phase
- Phase 36 trials
- Phase 2/32 trials
- Phase 21 trial
- Status
- Completed5 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Biohaven Therapeutics Ltd.3 trials
- Marinus Pharmaceuticals2 trials
- Xenon Pharmaceuticals Inc.2 trials
- Rapport Therapeutics Inc.1 trial
- Sk Life Science Inc.1 trial
Running trials
Recruiting
Enrolling by invitation
Active, not recruiting
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Enrolling by invitation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Epilepsy3 recruiting
Closed trials
Completed
Completed
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
Terminated
Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy
Completed
Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026